Effects of intraperitoneal melatonin on caustic sclerosing cholangitis due to scolicidal solution in a rat model

Current Therapeutic Research - Clinical and Experimental

Volumn 71, Issue 2, 2010, Pages 118-128

  Sezer, Atakan ^a   Hatipoglu, Ahmet Rahmi ^a   Usta, Ufuk ^a   Altun, Gülay ^a   Sut, Necdet ^a  

^a TRAKYA UNIVERSITY   (Turkey)

Author keywords

Caustic sclerosing cholangitis; Hydatid cyst; Melatonin; Scolicidal solutions

Indexed keywords

FORMALDEHYDE; M 5250; MELATONIN; PLACEBO; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BILIARY TRACT SCINTISCANNING; CELL FUNCTION; CONTROLLED STUDY; DISEASE SEVERITY; DNA FRAGMENTATION; DRUG ACTIVITY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HISTOPATHOLOGY; LIVER CELL; LIVER FUNCTION; LIVER SCINTISCANNING; NONHUMAN; PRIORITY JOURNAL; RAT; SCLEROSING CHOLANGITIS; TREATMENT RESPONSE;

EID: 77951972990     PISSN: 0011393X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.curtheres.2010.03.004     Document Type: Article

References (26)

1. Battelli G Echinococcosis: Costs, losses and social consequences of a neglected zoonosis. Vet Res Commun. 2009, 33(Suppl 1):47-52.
2. Agaoglu N, Türkyilmaz S, Arslan MK Surgical treatment of hydatid cysts of the liver. Br J Surg. 2003, 90:1536-1541.
3. Sahin M, Eryilmaz R, Bulbuloglu E The effect of scolicidal agents on liver and biliary tree (experimental study). J Invest Surg. 2004, 17:323-326.
4. Belghiti J, Benhamou JP, Houry S, et al. Caustic sclerosing cholangitis. A complication of the surgical treatment of hydatid disease of the liver. Arch Surg. 1986, 121:1162-1165.
5. Caccamo L, Ferla G, Gislon M, et al. Sclerosing cholangitis subsequent to surgical intervention for hepatic hydatidosis. A clinical case [in Italian]. Minerva Med. 1989, 80:865-868.
6. Castellano G, Moreno-Sanchez D, Gutierrez J, et al. Caustic sclerosing cholangitis. Report of four cases and a cumulative review of the literature. Hepatogastroenterology. 1994, 41:458-470.
7. Funariu G, Turdeanu N, Chirileanu T, et al. Sclerosing cholangitis in the evolution of a surgical hepatic hydatid cyst [in Romanian]. Chirurgia (Bucur). 1992, 41:32-42.
8. Houry S, Languille O, Huguier M, et al. Sclerosing cholangitis induced by formaldehyde solution injected into the biliary tree of rats. Arch Surg. 1990, 125:1059-1061.
9. Stoianov G, Genchev G, Dimitrov A Secondary sclerosing cholangitis after echinococcectomy [in Bulgarian]. Khirurgiia (Sofiia). 1998, 51:40-41.
10. Tasev V Sclerosing cholangitis after the surgical treatment of hepatic echinococcosis [in Bulgarian]. Khirurgiia (Sofiia). 1998, 51:47-50.
11. Terés J, Gomez-Moli J, Bruguera M, et al. Sclerosing cholangitis after surgical treatment of hepatic echinococcal cysts. Report of three cases. Am J Surg. 1984, 148:694-697.
12. Tsimoyiannis EC, Grantzis E, Moutesidou K, Lekkas ET Secondary sclerosing cholangitis: After injection of formaldehyde into hydatid cysts in the liver. Eur J Surg. 1995, 161:299-300.
13. Behrns KE, van Heerden JA Surgical management of hepatic hydatid disease. Mayo Clin Proc. 1991, 66:1193-1197.
14. Portincasa P, Vacca M, Moschetta A, et al. Primary sclerosing cholangitis: Updates in diagnosis and therapy. World J Gastroenterol. 2005, 11:7-16.
15. Hardeland R, Reiter RJ, Poeggeler B, Tan DX The significance of the metabolism of the neurohormone melatonin: Antioxidative protection and formation of bioactive substances. Neurosci Biobehav Rev. 1993, 17:347-357.
16. Eşrefoǧlu M, Gül M, Emre MH, et al. Protective effect of low dose of melatonin against cholestatic oxidative stress after common bile duct ligation in rats. World J Gastroenterol. 2005, 11:1951-1956.
17. Tan DX, Manchester LC, Reiter RJ, et al. Significance of melatonin in antioxidative defense system: Reactions and products. Biol Signals Recept. 2000, 9:137-159.
18. Montilla P, Cruz A, Padillo FJ, et al. Melatonin versus vitamin E as protective treatment against oxidative stress after extra-hepatic bile duct ligation in rats. J Pineal Res. 2001, 31:138-144.
19. Padillo FJ, Cruz A, Navarrete C, et al. Melatonin prevents oxidative stress and hepatocyte cell death induced by experimental cholestasis. Free Radic Res. 2004, 38:697-704.
20. Cruz A, Padillo FJ, Torres E, et al. Melatonin prevents experimental liver cirrhosis induced by thioacetamide in rats. J Pineal Res. 2005, 39:143-150.
21. Carossino AM, Lombardi A, Matucci-Cerinic M, et al. Effect of melatonin on normal and sclerodermic skin fibroblast proliferation. Clin Exp Rheumatol. 1996, 14:493-498.
22. Hatipoǧlu A, Türkyilmaz Z, Mert S The effects of melatonin on postoperative intraabdominal adhesion formation. Yonsei Med J. 2007, 48:659-664.
23. Sahna E, Parlakpinar H, Vardi N, et al. Efficacy of melatonin as protectant against oxidative stress and structural changes in liver tissue in pinealectomized rats. Acta Histochem. 2004, 106:331-336.
24. Messner M, Huether G, Lorf T, et al. Presence of melatonin in the human hepatobiliarygastrointestinal tract. Life Sci. 2001, 69:543-551.
25. Bruck R, Aeed H, Avni Y, et al. Melatonin inhibits nuclear factor kappa B activation and oxidative stress and protects against thioacetamide induced liver damage in rats. J Hepatol. 2004, 40:86-93.
26. Aust S, Thalhammer T, Humpeler S, et al. The melatonin receptor subtype MT1 is expressed in human gallbladder epithelia. J Pineal Res. 2004, 36:43-48.